Biotech

All Articles

Analysts examine Avidity's DMD win, exposing distinctions in information

.Avidity Biosciences pleased real estate investors along with phase 1/2 records in Duchenne muscular...

Actinogen's cortisol blocker stops working period 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually skipped the primary endpoint of a phase 2 study i...

Bivictrix decides going exclusive only means to take ADC right into center

.Antibody-drug conjugates (ADCs) have been at the facility of lots of a billion-dollar biobuck licen...

TPG leadings up funds to $580M for financial investments across life scientific researches

.Resource manager TPG, which has assisted biotechs such as Sionna Rehabs and also Santa Ana Bio, has...

Merck stops phase 3 TIGIT test in bronchi cancer for futility

.Merck &amp Co.'s TIGIT course has actually experienced one more trouble. Months after shuttering a ...

After a tough year, Exscientia folds up into Recursion

.After a year determined by pipeline hairstyles, the shift of its CEO and discharges, Exscientia wil...

Cullinan, after $25M offer, return bispecific to Harbour

.Cullinan Rehab was actually impressed good enough along with Port BioMed's bispecific immune system...

A deeper examine Brutal Biotech's Brutal 15

.In this particular week's incident of "The Top Pipe," we're diving in to Ferocious Biotech's annual...

Lilly faces stage 2 breakdown of tau-targeting med

.The confetti is still flying from Eli Lilly's party commemorating the approval of Alzheimer's healt...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings a...